5 recruiting, 4 completed, 2 active not recruiting, 2 unknown. 3 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Active not recruiting 2, Unknown 1 |
| Phase 1 | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Tumor Burden: new trials by email Literature Review of Tumor Burden trials Research Report on Tumor Burden
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Ta-NPs Plus Radiotherapy for Locally Recurrent Retroperitoneal Sarcoma Ta-NPs (2% Tumor Volume), Ta-NPs (5% Tumor Volume), Ta-NPs (10% Tumor Volume) - Locally Recurrent Retroperitoneal Soft Tissue Sarcoma | Phase 1 | Not yet recruiting | West China Hospital | 9 | 2026-05-01 | 2026-05-11 |
| Prospective Data Collection Initiative on Thoracic Malignancies Health-related quality of life and treatment outcome questionnaires, (Tumor) tissue and other biomaterials, Blood samples - Lung Cancer, Thoracic Cancer | Recruiting | Dutch Society of Physicians for Pulmonology and Tuberculosis | 12000 | 2025-08-15 | 2026-07-07 | |
| Osteolysis of Allograft Prosthetic Composite After Shoulder Resection for Tumors proximal humeral resection for tumor and allograft prosthetic composite reconstruction - Shoulder Disease | Unknown | Central Hospital, Nancy, France | 6 | 2024-05-01 | 2024-04-24 | |
| Test of CD47-SIRPĪ± Inhibitors on the Immune Microenvironment Colon Cancer BLOOD AND TUMOR - Cancer of the Colon | Recruiting | Institut Paoli-Calmettes | 115 | 2023-01-09 | 2024-10-09 | |
| Proteogenomic Signatures Analysis In Ovarian Cancer Tumor and blood sample - Ovarian Cancer | Not applicable | Active not recruiting | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 24 | 2022-11-17 | 2025-03-04 |
| Real Time Molecular Analysis of Breast Cancer Receiving Neo-adjuvant Chemotherapy molecular analysis of blood and tumor - Breast Cancer Female | Recruiting | Institut Paoli-Calmettes | 150 | 2022-11-03 | 2025-06-15 | |
| A Radiomic Model for Risk of Local Recurrence and DFS for T3 and T4 Non-small Cell Lung Cancer tumor and peritumor radiomic feature - Lung Cancer, Nonsmall Cell | Completed | Jinling Hospital, China | 200 | 2021-01-01 | 2024-05-09 | |
| HER2-PREDICT: Translational Study of Tumor Samples From Patients Treated With Trastuzumab Deruxtecan (T-DXd; DS-8201a) Tumor and Blood sample collection - Metastatic Cancer | Not applicable | Active not recruiting | SOLTI Breast Cancer Research Group | 180 | 2019-12-13 | 2025-09-09 |
| Impact of Tumour 1q Gain in French Pediatric and Young Adult Patients With Renal Tumours Radiologic Centralized Review, Tissue sample (tumor, sung, urine) - Kidney Cancer | Not applicable | Unknown | Assistance Publique Hopitaux De Marseille | 510 | 2019-08-01 | 2019-07-02 |
| Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver Codman 3000 constant flow pump catheter, Panitumumab, FUDR-Dex - Colorectal Cancer, Liver Metastases | Phase 2 | Completed | National Cancer Institute (NCI) | 24 | 2019-06-24 | 2026-08-28 |
| Next Generation " Pre-clinical Model for Colorectal Cancer Metastases and Hepatocellular Carcinomas Tumor /metastases removal - Colorectal Cancer Metastases and Hepatocellular Carcinomas | Completed | Assistance Publique Hopitaux De Marseille | 48 | 2019-06-06 | 2025-11-20 | |
| Prospective Pilot Study Identifying Clinically Relevant Biological Targets for Medical Therapy Tumor and Blood Specimens - Craniopharyngioma, Child | Enrolling by invitation | University of Colorado, Denver | 250 | 2019-03-12 | 2026-03-23 | |
| Constitution of ex Vivo Ovarian Tumor Models for the Validation of the Interest of Innovative Therapies and the Search for Tumor or Circulating Biomarkers Predictive of Treatment Response collection of blood, urine, tumor and ascite samples - Ovarian Cancer | Completed | Centre Francois Baclesse | 250 | 2019-03-07 | 2025-08-08 | |
| Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome Tumor and Marrow Markers - Neuroblastoma | Recruiting | Memorial Sloan Kettering Cancer Center | 2070 | 2000-09-26 | 2026-10-05 | |
| Esophageal Cancer Risk Registry Survey of client health, personal habits, family history, Blood specimen for non-DNA and DNA parts, Biopsy of esophageal/stomach tissue, lymph nodes, tumor - Esophageal Cancer, Gastroesophageal Reflux Disease (GERD) | Recruiting | University of Pittsburgh | 7000 | 1999-06-01 | 2026-04-14 |
Carcinoma, Non-Small-Cell Lung (2) · Ovarian Neoplasms (2) · Adenocarcinoma (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Squamous Cell (1) · Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Craniopharyngioma (1) · Esophageal Achalasia (1) · Esophageal Diseases (1) · Esophageal Neoplasms (1) · Gastroesophageal Reflux (1) · Hernia, Hiatal (1) · Kidney Neoplasms (1) · Lung Neoplasms (1)
Assistance Publique Hopitaux De Marseille (2) · Institut Paoli-Calmettes (2) · Central Hospital, Nancy, France (1) · Centre Francois Baclesse (1) · Dutch Society of Physicians for Pulmonology and Tuberculosis (1) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1) · Jinling Hospital, China (1) · Memorial Sloan Kettering Cancer Center (1) · National Cancer Institute (NCI) (1) · SOLTI Breast Cancer Research Group (1) · University of Colorado, Denver (1) · University of Pittsburgh (1) · West China Hospital (1)
France (6) · United States (4) · China (2) · Italy (1) · Netherlands (1) · Spain (1)
Camilla Nero (1) · Guangming Lu (1) · James D. Luketich, MD (1) · Jonathan M Hernandez, M.D. (1) · Nai-Kong Cheung, M.D., Ph.D. (1) · Todd Hankinson, MD (1) · W.K. de Jong, Dr. (1)
PMID 19672942, PMID 22072149, PMID 22327172, PMID 22416102, PMID 25528723, PMID 32154773, PMID 33219848, PMID 34550633, PMID 38849726
2019 (1)